Collection of Blood for Multiple Collaborative Studies

Description

This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.

Conditions

HIV

Talk to us

Study Overview

On this page

Study Details

Study overview

This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.

Collection and Preservation of Blood and Serum Specimens From HIV Positive or HIV Negative Patients for Multiple Collaborative Studies

Collection of Blood for Multiple Collaborative Studies

Condition
HIV
Intervention / Treatment

-

Contacts and Locations

San Francisco

San Francisco General Hospital, San Francisco, California, United States, 94110

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort
  • * HIV-positive subjects naive to antiretroviral therapy
  • * HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6 months
  • * Good venous access
  • * Able to provide informed consent
  • * Hemoglobin \< 9g/dl
  • * Hematocrit \< 27%
  • * Active treatment for cancer
  • * Hospitalization or IV antibiotic use within the last 4 months
  • * Immunosuppressive therapy within the last 4 months

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

University of California, San Francisco,

Steven Deeks, M.D., PRINCIPAL_INVESTIGATOR, University of Californa, San Francisco

Study Record Dates

2030-01